Press Releases
Lundbeck’s partner Mochida receives approval of Lexapro in Japan
H. Lundbeck A/S announced that our partner Mochida Pharmaceutical Co., Ltd. (Mochida) has obtained approval of Lexapro® 10 mg (escitalopram) from the Japanese Ministry...
Press Releases
Amgen and UCB Announce Positive Phase 2 Results of...
Amgen and UCB announced positive top-line results from their Phase 2 clinical study comparing sclerostin-antibody AMG 785/CDP7851 to placebo in postmenopausal women with low bone...
Press Releases
FDA Approves Roche’s HPV Test for Identifying Women at...
Roche announced that the US Food and Drug Administration (FDA) has approved the cobas HPV (Human Papillomavirus) Test which identifies women at highest risk...
Press Releases
BioSante Pharmaceuticals Announces Pancreatic and Prostate Cancer Vaccine License
BioSante Pharmaceuticals, Inc. announced it has licensed its Pancreas Cancer Vaccine and Prostate Cancer Vaccine to Aduro BioTech, a clinical-stage immunotherapy company, solely for use...
Press Releases
Trophos presents data at the American Academy of Neurology...
Trophos SA, a clinical stage pharmaceutical company developing innovative therapeutics from discovery to clinical validation for indications with under-served needs in neurology and cardiology, announces...
Press Releases
CIT strengthens services in immunotoxicology
CIT, a leading European CRO specializing in non-clinical health and safety research, is pleased to announce the appointment of a new multi-disciplinary team of experienced...
Press Releases
PharmaDiagnostics’ SoPRano (TM) wins prestigious product award at SBS...
PharmaDiagnostics NV, a company developing and marketing a broadly-enabling, label-free screening technology that uniquely does not require specialized equipment, announces today that their SoPRano(TM) technology...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.